Ragy R. Girgis

Deficits in Prefrontal Cortical and Extrastriatal Dopamine Release in Schizophrenia

Mark Slifstein, Elsmarieke van de Giessen, Jared X. Van Snellenberg et al. · JAMA Psychiatry · 2015 · 386 citations · Full text

Neuromelanin-sensitive MRI as a noninvasive proxy measure of dopamine function in the human brain

Clifford Cassidy, Fabio A. Zucca, Ragy R. Girgis et al. · Proceedings of the National Academy of Sciences · 2019 · 229 citations · Full text

A Randomized Exploratory Trial of an Alpha-7 Nicotinic Receptor Agonist (TC-5619) for Cognitive Enhancement in Schizophrenia

Jeffrey A. Lieberman, G. C. Dunbar, Anthony C. Segreti et al. · Neuropsychopharmacology · 2012 · 175 citations · Full text

Psychiatry, Psychotic Disorder, Medicine +11

Preferential binding to dopamine D3 over D2 receptors by cariprazine in patients with schizophrenia using PET with the D3/D2 receptor ligand [11C]-(+)-PHNO

Ragy R. Girgis, Mark Slifstein, Deepak Cyril D’Souza et al. · Psychopharmacology · 2016 · 124 citations · Full text

A Randomized, Double-Blind, Placebo-Controlled Clinical Trial of Tocilizumab, An Interleukin-6 Receptor Antibody, For Residual Symptoms in Schizophrenia

Ragy R. Girgis, Adam Ciarleglio, Tse Choo et al. · Neuropsychopharmacology · 2017 · 122 citations · Full text

Autoimmune Disease, Psychiatry, Psychotic Disorder +10